Specifications
Brand Name :
Combined detection reagent of troponin I, myoglobin and creatine kinase isoenzyme(cTnl/MYO/CK-MB)
Model Number :
cTnl/MYO/CK-MB
Certification :
CE
Place of Origin :
Henan,China
MOQ :
To be negotiated
Price :
To be negotiated
Supply Ability :
10000 Kit/Kit per Day
Delivery Time :
To be negotiated
Packaging Details :
Kit
Sample type :
Whole Blood,Serum,Plasma
Mixing requirements :
Mix well
Sample size after dilution :
60μL
Reaction time :
15min
Detection range :
cTnl:0.1~50ng/mL;MYO:10~200ng/mL;CK-MB:0.8~100ng/mL
Application Department :
Outpatient, emergency
Description

Combined Detection Reagent Of Troponin I,Myoglobin And Creatine Kinase Isoenzyme Performance Index

CTnI/MYO/CK-MB Overview


The troponin I/ myoglobin/creatine kinase isoenzyme (cTnI/ Myo /CK-MB) includes the following three indicators: The combined detection of troponin I (cTnI), myoglobin (Myo) and creatine kinase isoenzyme (CK-MB) is of great significance in the early diagnosis of acute myocardial diseases such as AMI

American Academy of Clinical Biochemistry (NACB) practice guidelines

All suspected patients with ACS should be tested for markers of myocardial necrosis

Troponin is the primary marker for the diagnosis of myocardial infarction

Myoglobin in combination with specific markers of myocardial necrosis, such as cTnI/CK-MB, may help to rule out or diagnose myocardial infarction more quickly

MYO CK-MB cTnI
molecular weight 17.8KD 86KD 22.5KD
Rise time 1-2h 4-6h 3-6h
Peak time 6-9h 24h 12-16h
recovery time 18-30h 2-3d 4-10d
Clinical value

1. The most important index of AMI was excluded in the early stage

2. Recurrent diagnosis of AMI, and the best evaluation index of reperfusion treatment effect

1. Estimate infarct size or reinfarct

2. The most valuable non-ST segment elevation marker of MI

1. Preferred markers for the diagnosis of AMI

2. Judge the infarct size and risk stratification

cTnI/MYO/CK-MB Performance Index


Detection range sample size Sample type Test time
cTnI MYO CK-MB 60μl Whole blood / serum / plasma 15min
0.1~50ng/mL 10~200ng/mL 0.8~100ng/mL

CTnI/MYO/CK-MB Clinical Significance


  • It is helpful for early diagnosis and risk stratification of acute coronary syndrome
  • Determine the area of myocardial ischemia injury
  • Differential diagnosis of various causes of chest pain
  • Monitoring of myocardial injury caused by various causes
  • Evaluation of the clinical efficacy of certain therapeutic agents

Possibility of outcome
cTnI CK-MB MYO Clinical possibility

+

+ + Myocardial infarction/myocardial injury can be diagnosed basically, and the occurrence time is 12-24 hours;
+ + - It can be basically diagnosed as myocardial infarction/myocardial injury, and the detection time is more than 1 day, which has passed the detection window period of Myo.
+ - - Myocardial infarction/myocardial injury has occurred for 2-3 days, and it is recommended to check again several hours later.
+ - + In patients with myocardial infarction/myocardial injury, the detection time may be longer than 3 days for symptoms, and patients suffer from reinjury or infarction size enlargement;
- + + Early myocardial infarction/myocardial injury/muscle injury, cTnI reexamination is recommended within 4-8 hours;

-

- + 1. Early myocardial infarction/myocardial injury, cTnI reexamination is recommended within 4-8 hours;
2. It may be caused by other injury diseases, such as creative work, skeletal muscle injury, liver and kidney disease;
- + - 1. For minor myocardial injury, it is recommended to reexamine cTnI within 4-8 hours;
2. It may be non-myocardial injury disease, and the detection time has passed the Myo window period;

-

- - Myocardial infarction/myocardial injury is basically ruled out. If highly suspected, it is recommended to check every 2 to 4 hours.

Application Department


Outpatient, emergency, physical examination center, cardiovascular, ICU, chest pain center and other departments

CTnI/MYO/CK-MB Clinical Comparison


Combined CTnI Myo CK-MB Rapid Test For Outpatient Emergency

Combined CTnI Myo CK-MB Rapid Test For Outpatient Emergency

Combined CTnI Myo CK-MB Rapid Test For Outpatient Emergency

Company profile


Combined CTnI Myo CK-MB Rapid Test For Outpatient EmergencyCombined CTnI Myo CK-MB Rapid Test For Outpatient EmergencyCombined CTnI Myo CK-MB Rapid Test For Outpatient EmergencyCombined CTnI Myo CK-MB Rapid Test For Outpatient Emergency

Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, microbial series, biochemical series and immune series reagents and supporting instruments.
The company has always adhered to the core concept of "fast and accurate, living up to life", committed to providing society with excellent products and services, and contributing to the cause of human health.

Send your message to this supplier
Send Now

Combined CTnI Myo CK-MB Rapid Test For Outpatient Emergency

Ask Latest Price
Brand Name :
Combined detection reagent of troponin I, myoglobin and creatine kinase isoenzyme(cTnl/MYO/CK-MB)
Model Number :
cTnl/MYO/CK-MB
Certification :
CE
Place of Origin :
Henan,China
MOQ :
To be negotiated
Price :
To be negotiated
Contact Supplier
Combined CTnI Myo CK-MB Rapid Test For Outpatient Emergency
Combined CTnI Myo CK-MB Rapid Test For Outpatient Emergency

Henan Lantian Medical Supplies Co.,Ltd.

Active Member
4 Years
henan, zhengzhou
Since 2016
Business Type :
Manufacturer, Exporter, Seller
Employee Number :
500~1000
Certification Level :
Active Member
Contact Supplier
Submit Requirement